Marditos roedores
La patente del oncorraton de Harvard sigue su tramite. Es un expediente con solera, nada menos que cosecha de 1985.
Basicamente, la patente reivindica(ba) un animal modificado geneticamente de tal manera que se le hacia susceptible a padecer cancer, con lo que se convertia en un paciente idoneo para los farmacos contra el cancer.
Estos dias se estan desarrollando las "vistas publicas" ante la Camara de Recursos de la EPO y, aunque en la página de la EPO se anuncia que duraran hasta el 09.07, parece que algunos ya conocen el resultado.
The European Patent Office on Tuesday upheld a Harvard University patent on a mouse genetically altered to develop cancer, but restricted its wording so that it applies only to mice and not to all species of rodents.
The pan-European patent, granted in 1992, protects the method of producing the animals. But the ruling, which closes a years-long legal battle with environmental groups, added further qualifications to a 2001 ruling that limited the patent to rodents, rather than mammals in general.
The patent office acknowledged concerns about ethical questions and animal rights, but also said the medical uses of the patent must be weighed.
A collection of church, environmental and animal protection groups, among them Greenpeace, had argued for the patent to be canceled, saying that it violated the dignity of living beings. After the 2001 ruling, six organizations filed an appeal.
Basicamente, la patente reivindica(ba) un animal modificado geneticamente de tal manera que se le hacia susceptible a padecer cancer, con lo que se convertia en un paciente idoneo para los farmacos contra el cancer.
Estos dias se estan desarrollando las "vistas publicas" ante la Camara de Recursos de la EPO y, aunque en la página de la EPO se anuncia que duraran hasta el 09.07, parece que algunos ya conocen el resultado.
The European Patent Office on Tuesday upheld a Harvard University patent on a mouse genetically altered to develop cancer, but restricted its wording so that it applies only to mice and not to all species of rodents.
The pan-European patent, granted in 1992, protects the method of producing the animals. But the ruling, which closes a years-long legal battle with environmental groups, added further qualifications to a 2001 ruling that limited the patent to rodents, rather than mammals in general.
The patent office acknowledged concerns about ethical questions and animal rights, but also said the medical uses of the patent must be weighed.
A collection of church, environmental and animal protection groups, among them Greenpeace, had argued for the patent to be canceled, saying that it violated the dignity of living beings. After the 2001 ruling, six organizations filed an appeal.
0 Comments:
Publicar un comentario
<< Home